Pacira(PCRX) - 2024 Q3 - Quarterly Results

FOR IMMEDIATE RELEASE NEWS RELEASE Pacira BioSciences Reports Third Quarter 2024 Financial Results -- Conference call today at 4:30 p.m. ET -- PARSIPPANY, NJ, November 6, 2024 - Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today reported financial results for the third quarter of 2024. Third Quarter 2024 Financial Highlights • Total revenues of $168.6 million • Net product sales of $132.0 million for EXPAREL, $28.4 million for ZILRETT ...